Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
47.04 USD | +0.45% | +10.19% | +678.81% |
Jun. 03 | Corbus Pharmaceuticals Reaches 2-Year High After Drug Results | DJ |
Jun. 03 | Oppenheimer Adjusts Corbus Pharmaceuticals Price Target to $80 From $60, Maintains Outperform Rating | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Equities
- CRBP Stock
- Revisions Corbus Pharmaceuticals Holdings, Inc.